WallStreetZenWallStreetZen

NASDAQ: RPHM
Reneo Pharmaceuticals Inc Stock

$1.66-0.04 (-2.35%)
Updated Jun 14, 2024
RPHM Price
$1.66
Fair Value Price
$0.87
Market Cap
$55.48M
52 Week Low
$0.98
52 Week High
$9.21
P/E
-0.76x
P/B
0.68x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$70.71M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
0.04
Operating Cash Flow
-$76M
Beta
0.73
Next Earnings
Aug 8, 2024
Ex-Dividend
N/A
Next Dividend
N/A

RPHM Overview

Reneo Pharmaceuticals Incorporated develops therapies for patients with rare genetic mitochondrial diseases. REN001 is a selective peroxisome proliferator-activated receptor delta agonist in (1) Phase IIb clinical trials in patients with primary mitochondrial myopathies, and (2) Phase 1b clinical trial in patients with long-chain fatty acid oxidation disorders and glycogen storage disease type V. Reneo Pharmaceuticals was incorporated in 2014 and is headquartered in San Diego, CA.

Zen Score

Industry Average (23)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how RPHM scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

RPHM ($1.66) is overvalued by 91.02% relative to our estimate of its Fair Value price of $0.87 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
RPHM ($1.66) is not significantly undervalued (91.02%) relative to our estimate of its Fair Value price of $0.87 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
RPHM is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more RPHM due diligence checks available for Premium users.

Be the first to know about important RPHM news, forecast changes, insider trades & much more!

RPHM News

Valuation

RPHM fair value

Fair Value of RPHM stock based on Discounted Cash Flow (DCF)
Price
$1.66
Fair Value
$0.87
Overvalued by
91.02%
RPHM ($1.66) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
RPHM ($1.66) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
RPHM is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

RPHM price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-0.76x
Industry
-10.23x
Market
30.51x

RPHM price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
0.68x
Industry
6.25x
RPHM is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

RPHM's financial health

Profit margin

Revenue
$0.0
Net Income
-$8.4M
Profit Margin
0%
RPHM's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials

Assets to liabilities

Assets
$84.6M
Liabilities
$3.4M
Debt to equity
0.04
RPHM's short-term assets ($83.93M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
RPHM's short-term assets ($83.93M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
RPHM's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$21.0M
Investing
$13.8M
Financing
$0.0
RPHM's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

RPHM vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
RPHM$55.48M-2.35%-0.76x0.68x
MURA$54.66M-2.12%N/A0.23x
ANEB$54.46M0.00%-5.68x10.92x
IMMX$54.41M-0.96%-2.22x1.95x
AEON$54.38M+2.21%-0.16x-0.36x

Reneo Pharmaceuticals Stock FAQ

What is Reneo Pharmaceuticals's quote symbol?

(NASDAQ: RPHM) Reneo Pharmaceuticals trades on the NASDAQ under the ticker symbol RPHM. Reneo Pharmaceuticals stock quotes can also be displayed as NASDAQ: RPHM.

If you're new to stock investing, here's how to buy Reneo Pharmaceuticals stock.

What is the 52 week high and low for Reneo Pharmaceuticals (NASDAQ: RPHM)?

(NASDAQ: RPHM) Reneo Pharmaceuticals's 52-week high was $9.21, and its 52-week low was $0.98. It is currently -81.98% from its 52-week high and 69.39% from its 52-week low.

How much is Reneo Pharmaceuticals stock worth today?

(NASDAQ: RPHM) Reneo Pharmaceuticals currently has 33,420,808 outstanding shares. With Reneo Pharmaceuticals stock trading at $1.66 per share, the total value of Reneo Pharmaceuticals stock (market capitalization) is $55.48M.

Reneo Pharmaceuticals stock was originally listed at a price of $13.89 in Apr 9, 2021. If you had invested in Reneo Pharmaceuticals stock at $13.89, your return over the last 3 years would have been -88.05%, for an annualized return of -50.74% (not including any dividends or dividend reinvestments).

How much is Reneo Pharmaceuticals's stock price per share?

(NASDAQ: RPHM) Reneo Pharmaceuticals stock price per share is $1.66 today (as of Jun 14, 2024).

What is Reneo Pharmaceuticals's Market Cap?

(NASDAQ: RPHM) Reneo Pharmaceuticals's market cap is $55.48M, as of Jun 15, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Reneo Pharmaceuticals's market cap is calculated by multiplying RPHM's current stock price of $1.66 by RPHM's total outstanding shares of 33,420,808.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.